Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Current Medicinal Chemistry|October 18, 2019
SKY59, A Novel Recycling Antibody for Complement-mediated DiseasesTaku Fukuzawa, Junichi Nezu
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 7, 2016
Predicting pharmacokinetic profile of therapeutic antibodies after iv injection from only the data after sc injection in cynomolgus monkeyKenta Haraya, Tatsuhiko Tachibana, Junichi Nezu
Drug Metabolism and Pharmacokinetics|July 24, 2017
Quantitative prediction of therapeutic antibody pharmacokinetics after intravenous and subcutaneous injection in humanKenta Haraya, Tatsuhiko Tachibana, Junichi Nezu
Drug Metabolism and Pharmacokinetics|March 6, 2016
PK/PD analysis of a novel pH-dependent antigen-binding antibody using a dynamic antibody-antigen binding modelKenta Haraya, Tatsuhiko Tachibana, Yuki Iwayanagi, et al.
Biochemical and Biophysical Research Communications|November 22, 2008
Anti-glypican 3 antibodies cause ADCC against human hepatocellular carcinoma cellsKiyotaka Nakano, Tetsuro Orita, Junichi Nezu, et al.
Antibodies (Basel, Switzerland)|May 23, 2023
Complement Activation by an Anti-Dengue/Zika Antibody with Impaired Fcγ Receptor Binding Provides Strong Efficacy and Abrogates Risk of Antibody-Dependent EnhancementZenjiro Sampei, Christine Xing'er Koo, Frannie Jiuyi Teo, et al.
Plos One|December 29, 2018
Antibody engineering to generate SKY59, a long-acting anti-C5 recycling antibodyZenjiro Sampei, Kenta Haraya, Tatsuhiko Tachibana, et al.
Antimicrobial Agents and Chemotherapy|February 9, 2011
Development of tetravalent, bispecific CCR5 antibodies with antiviral activity against CCR5 monoclonal antibody-resistant HIV-1 strainsJürgen Schanzer, Andreas Jekle, Junichi Nezu, et al.
Mabs|April 28, 2022
Elimination of plasma soluble antigen in cynomolgus monkeys by combining pH-dependent antigen binding and novel Fc engineeringYuji Hori, Ken Ohmine, Hitoshi Katada, et al.
Scientific Reports|April 4, 2017
Entire CD3ε, δ, and γ humanized mouse to evaluate human CD3-mediated therapeuticsOtoya Ueda, Naoko A Wada, Yasuko Kinoshita, et al.
Pageof 2